1 Janssen S, "The clinical heterogeneity of drug-induced myoclonus : an illustrated review" 264 : 1559-1566, 2017
2 Sutter R, "Myoclonus in the critically ill : diagnosis, management, and clinical impact" 127 : 67-80, 2016
3 Pei LJ, "Memantine-induced myoclonus precipitated by renal impairment and drug interactions" 63 : 2643-2644, 2015
4 Murgai AA, "Memantine-induced myoclonus in a patient with Alzheimer disease" 5 : 337-, 2015
5 Moritoyo T, "Effect of renal impairment on the pharmacokinetics of memantine" 119 : 324-329, 2012
6 Jimenez-Jimenez FJ, "Drug-induced myoclonus : frequency, mechanisms and management" 18 : 93-104, 2004
1 Janssen S, "The clinical heterogeneity of drug-induced myoclonus : an illustrated review" 264 : 1559-1566, 2017
2 Sutter R, "Myoclonus in the critically ill : diagnosis, management, and clinical impact" 127 : 67-80, 2016
3 Pei LJ, "Memantine-induced myoclonus precipitated by renal impairment and drug interactions" 63 : 2643-2644, 2015
4 Murgai AA, "Memantine-induced myoclonus in a patient with Alzheimer disease" 5 : 337-, 2015
5 Moritoyo T, "Effect of renal impairment on the pharmacokinetics of memantine" 119 : 324-329, 2012
6 Jimenez-Jimenez FJ, "Drug-induced myoclonus : frequency, mechanisms and management" 18 : 93-104, 2004